Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 15 |
NetGPI | no | yes: 0, no: 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0000428 | DNA-directed RNA polymerase complex | 4 | 16 |
GO:0030880 | RNA polymerase complex | 3 | 16 |
GO:0032991 | protein-containing complex | 1 | 16 |
GO:0055029 | nuclear DNA-directed RNA polymerase complex | 3 | 14 |
GO:0061695 | transferase complex, transferring phosphorus-containing groups | 4 | 16 |
GO:0140513 | nuclear protein-containing complex | 2 | 14 |
GO:0140535 | intracellular protein-containing complex | 2 | 16 |
GO:1902494 | catalytic complex | 2 | 16 |
GO:1990234 | transferase complex | 3 | 16 |
GO:0005634 | nucleus | 5 | 2 |
GO:0005665 | RNA polymerase II, core complex | 4 | 2 |
GO:0005666 | RNA polymerase III complex | 4 | 2 |
GO:0005736 | RNA polymerase I complex | 4 | 2 |
GO:0005737 | cytoplasm | 2 | 1 |
GO:0031974 | membrane-enclosed lumen | 2 | 1 |
GO:0031981 | nuclear lumen | 5 | 1 |
GO:0032838 | plasma membrane bounded cell projection cytoplasm | 4 | 1 |
GO:0043226 | organelle | 2 | 2 |
GO:0043227 | membrane-bounded organelle | 3 | 2 |
GO:0043229 | intracellular organelle | 3 | 2 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 2 |
GO:0043233 | organelle lumen | 3 | 1 |
GO:0070013 | intracellular organelle lumen | 4 | 1 |
GO:0097014 | ciliary plasm | 5 | 1 |
GO:0099568 | cytoplasmic region | 3 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
Related structures:
AlphaFold database: A4H9J0
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 16 |
GO:0006351 | DNA-templated transcription | 7 | 16 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 16 |
GO:0006807 | nitrogen compound metabolic process | 2 | 16 |
GO:0008152 | metabolic process | 1 | 16 |
GO:0009058 | biosynthetic process | 2 | 16 |
GO:0009059 | macromolecule biosynthetic process | 4 | 16 |
GO:0009987 | cellular process | 1 | 16 |
GO:0016070 | RNA metabolic process | 5 | 16 |
GO:0018130 | heterocycle biosynthetic process | 4 | 16 |
GO:0019438 | aromatic compound biosynthetic process | 4 | 16 |
GO:0032774 | RNA biosynthetic process | 5 | 16 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 16 |
GO:0034654 | nucleobase-containing compound biosynthetic process | 4 | 16 |
GO:0043170 | macromolecule metabolic process | 3 | 16 |
GO:0044237 | cellular metabolic process | 2 | 16 |
GO:0044238 | primary metabolic process | 2 | 16 |
GO:0044249 | cellular biosynthetic process | 3 | 16 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 16 |
GO:0046483 | heterocycle metabolic process | 3 | 16 |
GO:0071704 | organic substance metabolic process | 2 | 16 |
GO:0090304 | nucleic acid metabolic process | 4 | 16 |
GO:0097659 | nucleic acid-templated transcription | 6 | 16 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 16 |
GO:1901362 | organic cyclic compound biosynthetic process | 4 | 16 |
GO:1901576 | organic substance biosynthetic process | 3 | 16 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 16 |
GO:0003677 | DNA binding | 4 | 16 |
GO:0003824 | catalytic activity | 1 | 16 |
GO:0003899 | DNA-directed 5'-3' RNA polymerase activity | 6 | 16 |
GO:0005488 | binding | 1 | 16 |
GO:0016740 | transferase activity | 2 | 16 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 16 |
GO:0016779 | nucleotidyltransferase activity | 4 | 16 |
GO:0034062 | 5'-3' RNA polymerase activity | 5 | 16 |
GO:0097159 | organic cyclic compound binding | 2 | 16 |
GO:0097747 | RNA polymerase activity | 4 | 16 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 16 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 16 |
GO:1901363 | heterocyclic compound binding | 2 | 16 |
GO:0003887 | DNA-directed DNA polymerase activity | 5 | 1 |
GO:0034061 | DNA polymerase activity | 4 | 1 |
GO:0140097 | catalytic activity, acting on DNA | 3 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 114 | 116 | PF00675 | 0.559 |
CLV_NRD_NRD_1 | 137 | 139 | PF00675 | 0.773 |
CLV_NRD_NRD_1 | 274 | 276 | PF00675 | 0.353 |
CLV_NRD_NRD_1 | 87 | 89 | PF00675 | 0.599 |
CLV_PCSK_KEX2_1 | 114 | 116 | PF00082 | 0.541 |
CLV_PCSK_KEX2_1 | 137 | 139 | PF00082 | 0.773 |
CLV_PCSK_KEX2_1 | 87 | 89 | PF00082 | 0.599 |
CLV_PCSK_SKI1_1 | 170 | 174 | PF00082 | 0.587 |
CLV_PCSK_SKI1_1 | 197 | 201 | PF00082 | 0.475 |
CLV_PCSK_SKI1_1 | 88 | 92 | PF00082 | 0.656 |
DOC_CKS1_1 | 62 | 67 | PF01111 | 0.388 |
DOC_MAPK_DCC_7 | 137 | 145 | PF00069 | 0.496 |
DOC_MAPK_gen_1 | 137 | 145 | PF00069 | 0.675 |
DOC_MAPK_gen_1 | 170 | 180 | PF00069 | 0.470 |
DOC_MAPK_gen_1 | 200 | 209 | PF00069 | 0.432 |
DOC_MAPK_MEF2A_6 | 137 | 145 | PF00069 | 0.496 |
DOC_MAPK_MEF2A_6 | 173 | 180 | PF00069 | 0.417 |
DOC_MAPK_MEF2A_6 | 212 | 219 | PF00069 | 0.591 |
DOC_MAPK_RevD_3 | 261 | 276 | PF00069 | 0.481 |
DOC_USP7_MATH_1 | 159 | 163 | PF00917 | 0.598 |
DOC_USP7_MATH_1 | 68 | 72 | PF00917 | 0.591 |
DOC_USP7_MATH_1 | 74 | 78 | PF00917 | 0.654 |
DOC_USP7_UBL2_3 | 144 | 148 | PF12436 | 0.606 |
DOC_USP7_UBL2_3 | 185 | 189 | PF12436 | 0.385 |
DOC_USP7_UBL2_3 | 197 | 201 | PF12436 | 0.361 |
DOC_USP7_UBL2_3 | 44 | 48 | PF12436 | 0.343 |
DOC_WW_Pin1_4 | 180 | 185 | PF00397 | 0.471 |
DOC_WW_Pin1_4 | 261 | 266 | PF00397 | 0.513 |
DOC_WW_Pin1_4 | 61 | 66 | PF00397 | 0.493 |
LIG_14-3-3_CanoR_1 | 129 | 135 | PF00244 | 0.506 |
LIG_14-3-3_CanoR_1 | 14 | 20 | PF00244 | 0.363 |
LIG_APCC_ABBA_1 | 239 | 244 | PF00400 | 0.407 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.503 |
LIG_deltaCOP1_diTrp_1 | 53 | 61 | PF00928 | 0.418 |
LIG_FHA_1 | 129 | 135 | PF00498 | 0.578 |
LIG_FHA_1 | 208 | 214 | PF00498 | 0.460 |
LIG_FHA_2 | 230 | 236 | PF00498 | 0.529 |
LIG_FHA_2 | 70 | 76 | PF00498 | 0.556 |
LIG_LIR_Gen_1 | 120 | 128 | PF02991 | 0.493 |
LIG_LIR_Nem_3 | 312 | 318 | PF02991 | 0.487 |
LIG_Pex14_2 | 57 | 61 | PF04695 | 0.394 |
LIG_SH2_SRC | 103 | 106 | PF00017 | 0.452 |
LIG_SH2_STAP1 | 103 | 107 | PF00017 | 0.577 |
LIG_SH2_STAT5 | 28 | 31 | PF00017 | 0.385 |
LIG_SH2_STAT5 | 294 | 297 | PF00017 | 0.450 |
LIG_SH3_3 | 37 | 43 | PF00018 | 0.472 |
LIG_SH3_3 | 59 | 65 | PF00018 | 0.489 |
LIG_SUMO_SIM_par_1 | 204 | 210 | PF11976 | 0.374 |
LIG_TRAF2_1 | 3 | 6 | PF00917 | 0.450 |
LIG_TYR_ITIM | 292 | 297 | PF00017 | 0.461 |
MOD_CDK_SPK_2 | 180 | 185 | PF00069 | 0.420 |
MOD_CK1_1 | 77 | 83 | PF00069 | 0.760 |
MOD_CK2_1 | 184 | 190 | PF00069 | 0.420 |
MOD_CK2_1 | 229 | 235 | PF00069 | 0.521 |
MOD_CK2_1 | 261 | 267 | PF00069 | 0.483 |
MOD_CK2_1 | 69 | 75 | PF00069 | 0.485 |
MOD_GlcNHglycan | 223 | 227 | PF01048 | 0.483 |
MOD_GlcNHglycan | 311 | 314 | PF01048 | 0.301 |
MOD_GlcNHglycan | 33 | 36 | PF01048 | 0.434 |
MOD_GlcNHglycan | 75 | 79 | PF01048 | 0.624 |
MOD_GlcNHglycan | 83 | 86 | PF01048 | 0.698 |
MOD_GSK3_1 | 180 | 187 | PF00069 | 0.440 |
MOD_GSK3_1 | 309 | 316 | PF00069 | 0.521 |
MOD_GSK3_1 | 77 | 84 | PF00069 | 0.643 |
MOD_N-GLC_1 | 277 | 282 | PF02516 | 0.271 |
MOD_NEK2_1 | 128 | 133 | PF00069 | 0.473 |
MOD_NEK2_1 | 179 | 184 | PF00069 | 0.377 |
MOD_NEK2_1 | 277 | 282 | PF00069 | 0.422 |
MOD_NEK2_2 | 184 | 189 | PF00069 | 0.533 |
MOD_PIKK_1 | 277 | 283 | PF00454 | 0.401 |
MOD_PKA_1 | 201 | 207 | PF00069 | 0.427 |
MOD_PKA_2 | 128 | 134 | PF00069 | 0.519 |
MOD_PKA_2 | 298 | 304 | PF00069 | 0.475 |
MOD_PKA_2 | 69 | 75 | PF00069 | 0.596 |
MOD_Plk_1 | 277 | 283 | PF00069 | 0.471 |
MOD_Plk_4 | 15 | 21 | PF00069 | 0.374 |
MOD_Plk_4 | 202 | 208 | PF00069 | 0.423 |
MOD_Plk_4 | 298 | 304 | PF00069 | 0.461 |
MOD_Plk_4 | 313 | 319 | PF00069 | 0.461 |
MOD_ProDKin_1 | 180 | 186 | PF00069 | 0.464 |
MOD_ProDKin_1 | 261 | 267 | PF00069 | 0.513 |
MOD_ProDKin_1 | 61 | 67 | PF00069 | 0.501 |
MOD_SUMO_for_1 | 143 | 146 | PF00179 | 0.744 |
MOD_SUMO_for_1 | 90 | 93 | PF00179 | 0.787 |
MOD_SUMO_rev_2 | 2 | 10 | PF00179 | 0.429 |
MOD_SUMO_rev_2 | 93 | 100 | PF00179 | 0.757 |
TRG_DiLeu_BaEn_2 | 266 | 272 | PF01217 | 0.492 |
TRG_ENDOCYTIC_2 | 294 | 297 | PF00928 | 0.481 |
TRG_ENDOCYTIC_2 | 318 | 321 | PF00928 | 0.481 |
TRG_ER_diArg_1 | 113 | 115 | PF00400 | 0.597 |
TRG_ER_diArg_1 | 136 | 138 | PF00400 | 0.591 |
TRG_ER_diArg_1 | 86 | 88 | PF00400 | 0.600 |
TRG_NLS_MonoExtN_4 | 197 | 204 | PF00514 | 0.503 |
TRG_Pf-PMV_PEXEL_1 | 284 | 289 | PF00026 | 0.260 |
TRG_Pf-PMV_PEXEL_1 | 88 | 93 | PF00026 | 0.524 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8I4 | Leptomonas seymouri | 67% | 100% |
A0A0S4J1J5 | Bodo saltans | 34% | 100% |
A0A1X0P763 | Trypanosomatidae | 46% | 100% |
A0A3Q8ID21 | Leishmania donovani | 35% | 100% |
A0A3R7KXJ2 | Trypanosoma rangeli | 47% | 100% |
A0A3S5H734 | Leishmania donovani | 78% | 94% |
A4HXV2 | Leishmania infantum | 35% | 100% |
A4HXV3 | Leishmania infantum | 79% | 94% |
C9ZZV0 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% |
E9ARL5 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 35% | 100% |
E9ARL6 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 79% | 94% |
Q4QDW3 | Leishmania major | 78% | 100% |
Q4QDW4 | Leishmania major | 35% | 100% |
V5B6J4 | Trypanosoma cruzi | 46% | 100% |